ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

INVO INVO BioScience Inc

0.935
0.005 (0.54%)
Last Updated: 08:38:39
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
INVO BioScience Inc INVO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.005 0.54% 0.935 08:38:39
Open Price Low Price High Price Close Price Previous Close
0.95 0.935 0.9599 0.93
more quote information »

Recent News

Date Time Source Heading
5/06/202416:30EDGAR2Form 8-K - Current report
4/17/202409:25APSMicro Cap Massively Bid Up Before Opening Bell
4/16/202415:59GLOBEINVO Reports Fourth Quarter and Full Year 2023 Financial..
2/06/202409:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202408:01EDGAR2Form 8-K - Current report
1/23/202407:00GLOBENAYA Biosciences To Acquire Clinical Stage Gene Therapy..
1/17/202407:00GLOBEINVO Bioscience Files S-4 Registration and Preliminary Joint..
1/16/202416:29EDGAR2Form S-4 - Registration of securities, business combinations
1/10/202415:46EDGAR2Form 8-K/A - Current report: [Amend]
1/10/202415:05EDGAR2Form 8-K - Current report
1/03/202416:29EDGAR2Form 8-K - Current report
12/28/202316:04EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
12/28/202316:02EDGAR2Form 8-K - Current report
12/13/202316:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/13/202315:53EDGAR2Form 8-K - Current report
12/11/202307:00PRNUSNAYA Biosciences Announces Publication of New Data for its..
11/28/202316:18EDGAR2Form 8-K - Current report
11/28/202308:00PRNUSINVO Bioscience Regains Compliance with Nasdaq Minimum..
11/24/202312:08EDGAR2Form DEF 14A - Other definitive proxy statements
11/20/202315:59EDGAR2Form 8-K - Current report
11/13/202315:10EDGAR2Form 8-K - Current report
11/13/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:01PRNUSINVO Reports Record Third Quarter 2023 Financial Results
11/13/202308:23EDGAR2Form SC TO-C - Written communication relating to an issuer..
11/13/202308:21EDGAR2Form 8-K - Current report
11/13/202308:12EDGAR2Form PRE 14A - Other preliminary proxy statements
11/10/202308:00PRNUSNAYA Biosciences and INVO Bioscience Announce Appointment of..
11/09/202315:40PRNUSINVO Bioscience Announces Commencement of Waiver..
10/27/202308:00PRNUSFree Registration Is Now Open For Tribe Public's CEO and Q&A..
10/26/202315:56EDGAR2Form 8-K - Current report
10/24/202316:10EDGAR2Form 8-K - Current report
10/23/202306:30PRNUSINVO Bioscience and NAYA Biosciences Announce Definitive..
10/16/202305:15EDGAR2Form 8-K - Current report
10/11/202308:00PRNUSINVO to Participate in the Lytham Partners Fall 2023..
10/05/202315:28EDGAR2Form 8-K - Current report
10/03/202316:24EDGAR2Form 8-K - Current report
10/02/202316:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/29/202316:26EDGAR2Form 8-K - Current report
9/29/202315:05PRNUSINVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF..
9/28/202311:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/28/202311:30PRNUSINVO Reminds Shareholders to Cast Their Vote for Upcoming..
9/08/202315:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
9/01/202316:17EDGAR2Form 8-K - Current report
9/01/202308:55EDGAR2Form DEF 14A - Other definitive proxy statements
8/21/202315:33EDGAR2Form PRE 14A - Other preliminary proxy statements
8/14/202315:10EDGAR2Form 8-K - Current report
8/14/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202315:05PRNUSINVO Reports Second Quarter 2023 Financial Results
8/11/202315:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
8/11/202313:07EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock